PromarkerD IVD successfully developed and validated

Proteomics International announces successful performance validation results for a new advanced PromarkerD immunoassay In Vitro Diagnostic Test (IVD).

The PromarkerD test system will now be available using two technology platforms that can service the Laboratory Developed Test and the IVD markets.

The advanced PromarkerD immunoassay opens the way to further commercialisation
deals in USA, Japan, India and around the world.

Media Release